Botulinum toxin prefilled plastic syringe

US12324903B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12324903-B2
Application numberUS-202117534229-A
CountryUS
Kind codeB2
Filing dateNov 23, 2021
Priority dateFeb 3, 2015
Publication dateJun 10, 2025
Grant dateJun 10, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a prefilled plastic container, such as a plastic syringe, comprising an aqueous botulinum toxin formulation. The aqueous botulinum toxin formulation in the prefilled plastic container is stable for a prolonged time period. Furthermore, the present invention relates to a kit comprising the prefilled plastic container, and to the use of the prefilled plastic container for therapeutic and cosmetic purposes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A prefilled plastic container comprising an aqueous botulinum toxin formulation, wherein the toxin activity is not reduced by more than 25%, relative to the initial toxin activity, upon storage of the prefilled container for 12 months at 5° C. or 3 months at 25° C. 2. The prefilled plastic container of claim 1 , wherein the number of sub-visible particles of equal to or greater than 10 μm is below 1000/ml during storage for 6 to 24 months at 2° C. to 25° C. 3. The prefilled plastic container of claim 1 , wherein the pH value is not increased or decreased by more than 10%, relative to the initial pH value, during storage of the prefilled container for 6 to 24 months at 2° C. to 25° C., or wherein the pH of the aqueous botulinum toxin formulation during storage is maintained in the range of 6.1 to 7.3, or both. 4. The prefilled plastic container of claim 1 , wherein the botulinum toxin is present in the aqueous formulation at a concentration of 10 U/ml to 1000 U/ml. 5. The prefilled plastic container of claim 1 , wherein the aqueous botulinum toxin formulation in the prefilled container does not contain a buffer. 6. The prefilled plastic container of claim 1 , wherein the container is (i) a syringe, (ii) a vial, (iii) a carpule, or (iv) an ampoule. 7. The prefilled plastic container in the form of a prefilled plastic syringe of claim 6 comprising: (a) a plastic syringe barrel including a proximal end and a distal end, and a generally cylindrical wall extending therebetween and defining a barrel lumen, the syringe barrel having a distally projecting tip with a fluid passage extending therethrough and communicating with the barrel lumen, wherein the generally cylindrical wall has an interior surface optionally coated with a barrier layer, (b) a capping device having an outlet engaging portion sealingly engaging and closing the distal open outlet end of the syringe, wherein the outlet engaging portion is made of an elastomeric material that optionally has a coating on its surface, and (c) a plunger rod assembly which extends into the proximal end of the syringe barrel and includes a plunger stopper in sliding fluid-tight engagement with the cylindrical wall of the barrel lumen, wherein the plunger stopper is made of an elastomeric material, which optionally has a coating on at least a portion of the plunger stopper contacting the aqueous botulinum toxin formulation during storage and/or injection. 8. The prefilled plastic container in the form of a prefilled plastic syringe of claim 7 , wherein the barrier layer of the syringe barrel is a silicone-free layer or a silicone layer. 9. The prefilled plastic container in the form of a prefilled plastic syringe of claim 7 , wherein the elastomeric material of the outlet engaging portion and/or the plunger stopper is selected from isoprene rubber (IS), butadiene rubber (BR), butyl rubber, halogenated butyl rubber, and styrene-butadiene rubber, and mixtures thereof, or wherein the optional coating on the outlet engaging portion and/or the plunger stopper is a crosslinked silicone coating or a fluoropolymer coating, or wherein the elastomeric material of the outlet engaging portion and/or the plunger stopper is selected from isoprene rubber (IS), butadiene rubber (BR), butyl rubber, halogenated butyl rubber, and styrene-butadiene rubber, and mixtures thereof, and the optional coating on the outlet engaging portion and/or the plunger stopper is a crosslinked silicone coating or a fluoropolymer coating. 10. A kit comprising a prefilled plastic container according to claim 1 and, optionally, instructions for use of said prefilled plastic container. 11. A method for the treatment of a disease or condition caused by or associated with hyperactive cholinergic innervation of muscles or exocrine glands in a patient, the method comprising locally administering an effective amount of botulinum toxin to a muscle or exocrine gland of the patient by injection using the prefilled plastic container according to claim 1 . 12. A method for the cosmetic treatment of the skin, optionally for treating wrinkles of the skin and facial asymmetries, the method comprising locally administering an effective amount of botulinum toxin to a patient by intradermal, subdermal or subcutaneous injection using the prefilled plastic container according to claim 1 .

Assignees

Inventors

Classifications

  • Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking · CPC title

  • Devices for protection of the needle before use, e.g. caps (A61M5/50 takes precedence; for infusion spikes A61M5/1626; protectors for sharps A61B50/3001) · CPC title

  • Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit · CPC title

  • Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic {(ampoules or carpules A61J1/06)} · CPC title

  • Enzymes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12324903B2 cover?
The present invention relates to a prefilled plastic container, such as a plastic syringe, comprising an aqueous botulinum toxin formulation. The aqueous botulinum toxin formulation in the prefilled plastic container is stable for a prolonged time period. Furthermore, the present invention relates to a kit comprising the prefilled plastic container, and to the use of the prefilled plastic conta…
Who is the assignee on this patent?
Merz Pharma Gmbh & Co Kgaa
What technology area does this patent fall under?
Primary CPC classification A61M5/31513. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).